Opportunity Overview
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Furosemide Tablets. Procurement details follow.
Furosemide Tablets: 20 MG and 40 MG in 90 and 1,000 count bottles and 80 MG in 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Nancy Fernandez at (445) 737-0713 or Nancy.Fernandez@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is April of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Furosemide Tablets: 20 MG and 40 MG in 90 and 1,000 count bottles and 80 MG in 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Nancy Fernandez at (445) 737-0713 or Nancy.Fernandez@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is April of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
This is one of 133 active United States Pharmaceuticals opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | DLA Troop Support |
|---|---|
| Country | United States |
| Category | Pharmaceuticals |
| NAICS | 325412 |
| PSC | 6505 |
| Published | March 12, 2026 |
| Response due | Not specified / rolling |
| Status | Active - open for responses |
| Official source | View original notice |
Related Opportunities in United States
See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →